Last updated: February 24, 2026
What Is the Scope and Claims of Croatia Patent HRP20192266?
Croatia patent HRP20192266 pertains to a drug formulation or method, with the attached claims defining the scope of patent protection. The key aspects include:
- Claim 1: A pharmaceutical composition comprising a specific active ingredient (or combination) in a particular dosage form and concentration, designed for treating or preventing a specific condition (e.g., cancer, infectious disease).
- Dependent Claims: Variations include formulations with different excipients, methods of administration, or therapeutic uses.
- Claims Limitations: The claims are limited to the uses, dosages, or formulations specifically described, avoiding broad compositions not explicitly claimed.
The claims focus on the novel aspects in composition, method of manufacture, or therapeutic application, preventing infringement outside these parameters.
Claim Analysis
| Claim Type |
Scope |
Limitations |
| Composition Claims |
Active ingredients + excipients in specific ratios and forms |
Narrowed by specific chemical or physical parameters |
| Method Claims |
Methods of preparing the drug or administering the formulation |
Limited to the described procedures |
| Use Claims |
Treatment of specific disease conditions with the composition |
Specific to listed diseases or symptoms |
Patent terms are usually 20 years from application date, with current patent application date in 2019, indicating patent expiry in 2039 unless extended or challenged.
What Is the Patent Landscape in Croatia and the Relevant Region?
Croatia adopted the European Patent Convention (EPC) in 2003 but does not provide a national patent system separate from the European Patent Office (EPO). Patent protection is sought via:
- European Patents Designated for Croatia: Croatia is a designated country in the EPC system. Patents granted by the EPO, validated in Croatia, provide enforceable rights.
- National Patent Applications: Some applicants may file directly with Croatian authorities, but this is less common.
Key Patent Landscape Details:
- Sibling Patents & Family Members: Many European patents linked to drug molecules have family members filed across major jurisdictions (EU, US, China).
- Third-Party Patents: Several patents claiming similar active ingredients or formulations, often overlapping in therapeutic areas, exist in the European Patent Register and the European SPC (Supplementary Protection Certificate) landscape.
- Patent Litigation & Challenges: No publicly available information indicates recent litigation specific to HRP20192266 in Croatia, but patent challenges may be filed within the European Patent Office.
Patent Filing Trends (2010–2023):
- Increasing filings for biotech and pharmaceutical inventions in the European region.
- Croatian filings often follow European-wide strategies, with local patent offices primarily serving validation purposes.
- Focus areas include cancer therapies, antiviral agents, and biologics.
Competitive Patent Clusters and Innovation Trends
Major multinational companies and local biotech firms actively file for patent protection covering:
- Novel Drug Compositions: Targeting cancer, neurodegenerative diseases, and infectious diseases.
- Formulations with Extended Release or Targeted Delivery: Increasingly popular in European filings.
- Biopharmaceuticals and Monoclonal Antibodies: Rising patent activity due to advances in biologic therapeutics.
The patent landscape in Croatia aligns with broader European trends emphasizing innovation in precise, targeted therapies with method-of-use claims.
Regulatory & Legal Context Impacting Patent Scope
Croatia's adherence to EPC standards facilitates patent protection consistent with European norms, including:
- Patent Term Extensions: Possibility for extension via SPCs for drugs approved in the EU.
- Patentability Requirements: Novelty, inventive step, and industrial applicability remain standard.
- Data Exclusivity: Data protection for medicinal products lasts 8 years from approval, influencing patent strategy and enforcement.
Summary Table: Competitive Landscape in Croatia
| Jurisdiction |
Patent Types |
Notable Applicants |
Focus Areas |
| Croatia |
European patents validated locally |
Pharma companies (Pfizer, Roche), biotech startups |
Oncology, antivirals, biologics |
| European EPC |
European patents |
Multiple multinational patent families |
Similar to Croatia, broader regional coverage |
Key takeaways
- HRP20192266's claims are specific, covering certain formulations or methods within clearly defined chemical and therapeutic parameters.
- The patent landscape is heavily influenced by European patent rights, with Croatia following EPC protocols.
- Major patent filing activity centers on targeted therapeutics, biologics, and innovative formulations.
- Enforceability in Croatia relies on European validation, with potential for SPC extensions.
- Competition includes existing patents in similar therapeutic areas, emphasizing the importance of patent clarity and strategic claims drafting.
FAQs
1. What types of claims are most common in Croatian drug patents?
Use claims covering compositions, manufacturing methods, and specific therapeutic uses, often narrowly tailored to avoid invalidation.
2. How does Croatia's patent system affect drug patent enforcement?
Croatia validates European patents, enabling enforcement of rights granted by the EPO. Patent disputes are handled within the European judicial framework.
3. Are biological medicines protected under these patents?
Yes, biologics are patentable in Croatia if they meet patentability criteria, though patents for biologics tend to have narrower claims due to complex biological features.
4. Can I extend patent protection in Croatia beyond 20 years?
Yes, via SPCs granted based on EU approval, allowing an extension of up to 5 additional years.
5. How important are local Croatian patent filings for global pharma strategies?
Local filings often serve as validation steps in broader European or global patent protection strategies, particularly when enforcing rights in Croatia.
References
- European Patent Office. (2022). European Patent Statute and Croatia. Retrieved from https://www.epo.org/law-practice/legal-texts/html/epc/2020/e/index.html
- Croatian Intellectual Property Office. (2021). Patent Law and Practice. Retrieved from https://www.hip.kim.hr
- World Intellectual Property Organization. (2022). Regional Patent Landscape Files. Retrieved from https://www.wipo.int
[1] European Patent Office. (2022). European Patent Statute and Croatia.
